ID
29055
Descrição
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Palavras-chave
Versões (5)
- 05/10/2017 05/10/2017 -
- 22/02/2018 22/02/2018 -
- 22/02/2018 22/02/2018 -
- 22/02/2018 22/02/2018 -
- 17/09/2021 17/09/2021 -
Titular dos direitos
gsk
Transferido a
22 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Ropinirole Case Report Form GSK RRL100013
STATUS OF TREATMENT BLIND
Descrição
PGx-PHARMACOGENETIC RESEARCH INSTRUCTIONS
Descrição
The question "Has informed consent been obtained for PGx-Pharmacogenetic research?" should be completed at the beginning of the study. If the question is answered No, I/ one box for reason and do not complete the remainder of the page. WITHDRAWAL OF CONSENT The question "Has the subject withdrawn consent for PGx-Pharmacogenetic research?" must be completed immediately if the subject withdraws consent. Otherwise, it must be completed when the subject leaves the study. It must be completed for all subjects for whom informed consent was obtained for PGx-Pharmacogenetic research. If consent is withdrawn, a request for destruction must be made and Blood Sample Destruction section below completed. BLOOD SAMPLE DESTRUCT/ON Do not complete this section if a blood sample was not collected. The question "Has a request been made for sample destruction?" must be completed immediately if there is a request for sample destruction. Otherwise, it must be completed when the subject leaves the study. It must be completed for all subjects for whom a blood sample was obtained for PGx-Pharmacogenetic research. If the question is answered Yes, I/one box for reason.
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0031325
- UMLS CUI [1,2]
- C1442085
Descrição
PGx-PHARMACOGENETIC RESEARCH
Descrição
CONSENT FOR PGx-PHARMACOGENETIC RESEARCH
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Descrição
Informed consent if yes
Tipo de dados
date
Alias
- UMLS CUI [1]
- C2985782
Descrição
Informed consent if no
Tipo de dados
text
Alias
- UMLS CUI [1]
- C0021430
Descrição
BLOOD SAMPLE COLLECTION
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0005834
Descrição
If Yes, record the date sample taken
Tipo de dados
date
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C0011008
Descrição
WITHDRAWAL OF CONSENT
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C1707492
Descrição
BLOOD SAMPLE DESTRUCTION
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
Descrição
If Yes: BLOOD SAMPLE DESTRUCTION
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
Descrição
The following lists of abbreviations are examples which can be used to aid the completion of the appropriate items on the Concomitant Medications page. These are not all inclusive lists and are for guidance only, other abbreviations not listed may be used if necessary.
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2347852
Descrição
UNITS
Tipo de dados
text
Alias
- UMLS CUI [1]
- C1519795
Similar models
STATUS OF TREATMENT BLIND
C2347038 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C1442085 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)